期刊文献+

老年晚期非小细胞肺癌的靶向治疗 被引量:7

Targeted Therapy for Advanced Non-Small Cell Lung Cancer in the Elderly
下载PDF
导出
摘要 非小细胞肺癌约占全部肺癌的85%,约70%患者在确诊时处于不能手术的局部晚期或已有转移,化疗是这些患者主要的治疗方法。当今老年肺癌患者日益增多,美国肺癌患者的中位确诊年龄为70岁,近16年80岁以上肺癌患者增加了50%,而70岁以下肺癌患者只增加了30%,肺癌已成为老年性疾病。流行病学上65岁是老年患者的分界年龄。在肺癌的临床试验中,70岁以上患者常常被排除在外。有关老年肺癌患者年龄的界定,医学上没有明确规定,现大多数研究将70岁视为老年肺癌患者的分界年龄。随机临床试验已证明,老年肺癌患者可以从单药化疗获益。
出处 《中国肺癌杂志》 CAS 2009年第7期821-825,共5页 Chinese Journal of Lung Cancer
  • 相关文献

参考文献14

  • 1Owonikoko TK, gagin CC, Belani CP, et al. Lung cancer in elderly patieats: an analysis of the surveillance, epidemiolog)5 and end results database. J Clin Oncol, 2007, 25 (35): 5570- 5577.
  • 2Jackman DM, Yeap BY, Lindeman NI, et al. Phase II clinical trial of chemo- therapy-naive patients > or = 70 years of age treated with erlotinib for ad- vanced non-small-celllung cancer.J Clin Oncol, 2007, 25(7): 760-766.
  • 3Ebi N, Semba H, Tokunaga SJ, et al. A phase II trial of gefitinib monotherapy in chemotherapy-naive patients of 7S years or older with advanced non-small cell lung cancer.J Thorac Oncol, 2008, 3(10): 1166-1171.
  • 4Crino L, Cappuzzo F, Zafloukal P, et al. Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study. J Clin Oncol, 2008, 26(26): 4253-4260.
  • 5姜宏宁,史崑,余敏.吉非替尼一线治疗老年非小细胞肺癌的临床观察[J].实用癌症杂志,2008,23(4):402-405. 被引量:8
  • 6Ramalingam SS, Dahlberg SE, Langer CJ, et al. Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599. J Clin Oncol, 2008, 26( 1): 60-65.
  • 7王金万,孙燕,刘永煜,于起涛,张沂平,李凯,朱允中,周清华,侯梅,管忠震,李维廉,庄武,王东林,梁后杰,秦凤展,卢辉山,刘晓晴,孙红,张燕军,王杰军,罗素霞,杨瑞合,涂远荣,王秀问,宋恕平,周静敏,游丽芬,王竞,姚晨.重组人血管内皮抑素联合NP方案治疗晚期NSCLC随机、双盲、对照、多中心Ⅲ期临床研究[J].中国肺癌杂志,2005,8(4):283-290. 被引量:625
  • 8Wheatley-Price P, Ding K, Seymour L, et al. Erlotinib for advanced non-small- cell lung cancer in the elderly: an analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21. J Clin Oncol, 2008, 26(14): 2350-2357.
  • 9Hotta K, Ueoka H, Kiura K, et al. Safety and efficacy of gefitinib treatment in elderly patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience. Acta Oncol, 2005, 44(7): 717-722.
  • 10张力,王淑兰,张晓彤,李龙芸,王孟昭.吉非替尼单药治疗老年晚期非小细胞肺癌患者的临床观察[J].中华内科杂志,2007,46(5):392-395. 被引量:10

二级参考文献69

共引文献645

同被引文献64

  • 1杨学宁,吴一龙.口服小分子靶向治疗药物吉非替尼[J].临床药物治疗杂志,2005,3(2):56-59. 被引量:13
  • 2管忠震,张力,李龙芸,蒋国梁,刘叙仪,储大同,赵洪云,李玮.吉非替尼治疗局部晚期或转移性非小细胞肺癌在中国的临床研究[J].癌症,2005,24(8):980-984. 被引量:114
  • 3韩宝惠.肺癌分子靶向治疗:更多的希望、更多的选择[J].中国肺癌杂志,2005,8(5):370-374. 被引量:3
  • 4温浙盛,陈晓勤,吴海鹰,韦蔚东,戎铁华.吉非替尼治疗不同类型晚期非小细胞肺癌患者的疗效比较[J].癌症,2007,26(4):415-417. 被引量:8
  • 5谷铣之,殷蔚伯,刘泰福.肿瘤放射治疗学[M].4版.北京:中国协和医科大学出版社,2008:47.
  • 6Fukuoka M,Yano S,Giaccone G,et al.Multi-institutional randomized phase II trial of gefinitib for previously treated patients with advanced non-small-cell lung cancer[J].J Clin Oncol,2003,21(12):2237-2246.
  • 7Kris MG,Natale RB,Herbst RS,et al.A phase II trial of ZD1839(Iressa) in advanced non-small-cell lung cancer (NSCLC) patients who had failed platinum-and docetaxel-based regimens(IDEAL-2)[J].Pro Am Soc Clin Oncol,2002,21:292.
  • 8Herbst RS,Giaccone G,Schiller JH,et al.Gefitinib in combination with paclitaxel and carbop latin in advanced non-small-cell lung cancer:a phase III trial-INTACT 2[J].J Clin Oncol,2004,22(5):785.
  • 9Lynch TJ,Bell DW,Sordella R,et al.Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib[J].N Engl J Med,2004,350(21):2129-2139.
  • 10Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1 ). Eur J Cancer,2009,45:261-267.

引证文献7

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部